Prostate cancer patients in Nashville and Los Angeles are benefiting from a computer-based decision aid that implements the latest study results to tailor treatment options to an individual’s quality-of-life priorities.

The Terry Burke Fund for Bladder Cancer Research at Vanderbilt-Ingram Cancer Center is supporting a range of discovery research aimed at improving outcomes for bladder cancer patients, and it is helping train the next generation of bladder cancer physician-scientists.

Daniel Barocas, MD, MPH, associate professor of Urology, is being recognized with a national award from the Society of Urologic Oncology (SUO) for his efforts to develop urologic cancer quality measures.

Vanderbilt urologic surgeons are offering an alternative therapy for prostate cancer patients considered to be low-to-intermediate risk, a middle ground between active surveillance and aggressive therapy.

Local comedian Ashley Corby, 35, overshares with her audience as part of her standup routine, including a 5-minute bit about “shady” rest areas she has visited due to interstitial cystitis (IC), a bladder pain syndrome affecting 3 million to 8 million people in the United States.

“When it’s you, it’s a whole different feeling,” Orrin Ingram said, gazing at logs burning in the fireplace.

Beginning July 1, Vanderbilt University Medical Center’s Department of Urologic Surgery, which is currently housed within the Medical Center’s Section of Surgical Sciences, will become an independent department.